{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:05:19Z","timestamp":1790949919655,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.semarthrit.2018.02.002","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T12:44:06Z","timestamp":1518612246000},"page":"263-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Dactylitis: A hallmark of psoriatic arthritis"],"prefix":"10.1016","volume":"48","author":[{"given":"Gurjit S.","family":"Kaeley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihi","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel Z.","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwin","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bakewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2018.02.002_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.berh.2012.09.004","article-title":"MRI and ultrasonography for diagnosis and monitoring of psoriatic arthritis","volume":"26","author":"Coates","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jaad.2013.07.023","article-title":"Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European\/North American dermatology clinics","volume":"69","author":"Mease","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/keq262","article-title":"Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program","volume":"50","author":"Gladman","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl 2","key":"10.1016\/j.semarthrit.2018.02.002_bib4","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/rheumatology\/keg217","article-title":"Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study","volume":"42","author":"McHugh","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/rheumatology\/ker216","article-title":"Work disability in psoriatic arthritis: a systematic review","volume":"51","author":"Tillett","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1136\/ard.2005.039826","article-title":"Clinical and radiological damage in psoriatic arthritis","volume":"65","author":"Siannis","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib8","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.3899\/jrheum.150165","article-title":"The Swedish Early Psoriatic Arthritis Registry 5-year followup: substantial radiographic progression mainly in men with high disease activity and development of dactylitis","volume":"42","author":"Geijer","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib9","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/rheumatology\/keg384","article-title":"A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience","volume":"42","author":"Kane","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib10","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.3899\/jrheum.091315","article-title":"Effect of psoriatic arthritis according to the affected categories of the international classification of functioning, disability and health","volume":"37","author":"Taylor","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13075-016-0977-2","article-title":"Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey","volume":"18","author":"Ramonda","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib12","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","article-title":"Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis","volume":"74","author":"Haroon","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0049-0172(98)80027-9","article-title":"Dactylitis: implications for clinical practice","volume":"28","author":"Rothschild","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/03009740600906677","article-title":"Dactylitis, a term for different digit diseases","volume":"35","author":"Olivieri","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib15","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1136\/ard.2008.094946","article-title":"Treatment recommendations for psoriatic arthritis","volume":"68","author":"Ritchlin","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11926-006-0062-y","article-title":"Dactylitis: pathogenesis and clinical considerations","volume":"8","author":"Healy","year":"2006","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib17","first-page":"2","article-title":"Drumstick dactylitis: an unusual presentation of sarcoid","author":"Weaver","year":"2003","journal-title":"Internet J Dermatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib18","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/ard.2003.018184","article-title":"Dactylitis in psoriatic arthritis: a marker for disease severity?","volume":"64","author":"Brockbank","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib19","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/ard.2010.129379","article-title":"Development of a preliminary composite disease activity index in psoriatic arthritis","volume":"70","author":"Mumtaz","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/annrheumdis-2012-201341","article-title":"The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)","volume":"72","author":"Helliwell","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib22","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3899\/jrheum.110278","article-title":"Development of a disease severity and responder index for psoriatic arthritis (PsA)\u2014report of the OMERACT 10 PsA special interest group","volume":"38","author":"Coates","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.berh.2010.05.004","article-title":"Disease measurement\u2014enthesitis, skin, nails, spine and dactylitis","volume":"24","author":"Coates","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib24","article-title":"Optimisation of rheumatology indices: dactylitis and enthesitis in psoriatic arthritis","volume":"32","author":"Ferguson","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/rheumatology\/kem315","article-title":"MRI changes in psoriatic dactylitis\u2014extent of pathology, relationship to tenderness and correlation with clinical indices","volume":"47","author":"Healy","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/ard.57.1.61a","article-title":"Dactylitis also involving the synovial sheaths in the palm of the hand: two more cases studied by magnetic resonance imaging","volume":"57","author":"Padula","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib27","first-page":"1626","article-title":"Dactylitis of the thumb extending to the radial bursa","volume":"30","author":"Olivieri","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib28","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1136\/annrheumdis-2015-207980","article-title":"Incidence and predictors for cardiovascular events in patients with psoriatic arthritis","volume":"75","author":"Eder","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/OARRR.S60821","article-title":"Optimal management of dactylitis in patients with psoriatic arthritis","volume":"7","author":"Yamamoto","year":"2015","journal-title":"Open Access Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib30","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/art.1780390912","article-title":"Dactylitis in patients with seronegative spondylarthropathy. Assessment by ultrasonography and magnetic resonance imaging","volume":"39","author":"Olivieri","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib31","first-page":"926","article-title":"Toe dactylitis in patients with spondyloarthropathy: assessment by magnetic resonance imaging","volume":"24","author":"Olivieri","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib32","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1002\/art.10633","article-title":"Fast spin echo-T2-weighted sequences with fat saturation in dactylitis of spondylarthritis. No evidence of entheseal involvement of the flexor digitorum tendons","volume":"46","author":"Olivieri","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib33","first-page":"1746","article-title":"Ultrasonography in the diagnosis and management of psoriatic dactylitis","volume":"26","author":"Kane","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1469-7580.2001.19950503.x","article-title":"The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites","volume":"199","author":"Benjamin","year":"2001","journal-title":"J Anat"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib35","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/1529-0131(199906)42:6<1080::AID-ANR2>3.0.CO;2-7","article-title":"Psoriatic arthritis: a unified concept twenty years on","volume":"42","author":"McGonagle","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/annrheumdis-2014-205839","article-title":"High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis","volume":"74","author":"Tan","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ni.3347","article-title":"Epigenetic regulation of the expression of Il12 and Il23 and autoimmune inflammation by the deubiquitinase Trabid","volume":"17","author":"Jin","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib38","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jbspin.2006.01.019","article-title":"Extrasynovial ultrasound abnormalities in the psoriatic finger. Prospective comparative power-doppler study versus rheumatoid arthritis","volume":"73","author":"Fourni\u00e9","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib39","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.rdc.2016.07.012","article-title":"Imaging evaluation of the entheses: ultrasonography, MRI, and scoring of evaluation","volume":"42","author":"D'Agostino","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib40","doi-asserted-by":"crossref","first-page":"R188","DOI":"10.1186\/ar3516","article-title":"Ultrasound in the evaluation of enthesitis: status and perspectives","volume":"13","author":"Gandjbakhch","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/BOR.0000000000000155","article-title":"Targeting extra-articular manifestations in PsA: a closer look at enthesitis and dactylitis","volume":"27","author":"Siegel","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib42","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/art.33415","article-title":"HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype","volume":"64","author":"Winchester","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/ard.2011.155044","article-title":"Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis","volume":"71","author":"Eder","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/annrheumdis-2014-205461","article-title":"Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype","volume":"25","author":"Haroon","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.0105-2896.2009.00865.x","article-title":"From HLA-B27 to spondyloarthritis: a journey through the ER","volume":"233","author":"Colbert","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib46","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.autrev.2014.01.050","article-title":"The IL-23\/IL-17 axis in psoriatic arthritis","volume":"13","author":"Suzuki","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib47","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib48","doi-asserted-by":"crossref","first-page":"E3669","DOI":"10.1073\/pnas.1405798111","article-title":"Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice","volume":"111","author":"Khmaladze","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib49","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00296-016-3436-0","article-title":"Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies","volume":"36","author":"Elyoussfi","year":"2016","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib50","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/rheumatology\/kew229","article-title":"Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis","volume":"55","author":"Behrens","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib51","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00296-014-2956-8","article-title":"Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease?","volume":"34","author":"Perez-Alamino","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib52","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3899\/jrheum.130643","article-title":"Ultrasound and magnetic resonance imaging in the evaluation of psoriatic dactylitis: status and perspectives","volume":"40","author":"Bakewell","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib53","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1186\/2193-1801-3-759","article-title":"Simple clinical indicators for early psoriatic arthritis detection","volume":"3","author":"Caso","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib54","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1586\/1744666X.2016.1146133","article-title":"Assessing disease activity in psoriasis and psoriatic arthritis: impact on management and therapy","volume":"12","author":"Chandran","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/art.11417","article-title":"Assessment of patients with psoriatic arthritis: a review of currently available measures","volume":"50","author":"Gladman","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib56","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.rdc.2015.07.003","article-title":"Clinical features and diagnostic considerations in psoriatic arthritis","volume":"41","author":"Gladman","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"issue":"Suppl 11","key":"10.1016\/j.semarthrit.2018.02.002_bib57","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1002\/acr.20577","volume":"63","author":"Mease","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib58","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib59","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000343607","article-title":"Ultrasonographic assessment of nail in psoriatic disease shows a link between onychopathy and distal interphalangeal joint extensor tendon enthesopathy","volume":"225","author":"Aydin","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib60","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.7863\/jum.2009.28.11.1569","article-title":"High-frequency sonography in the evaluation of psoriasis: nail and skin involvement","volume":"28","author":"Gutierrez","year":"2009","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10067-009-1292-y","article-title":"A sonographic spectrum of psoriatic arthritis: \u201cthe five targets\u201d","volume":"29","author":"Gutierrez","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000351702","article-title":"Potential use of optical coherence tomography and high-frequency ultrasound for the assessment of nail disease in psoriasis and psoriatic arthritis","volume":"227","author":"Aydin","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib63","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jbspin.2016.10.005","article-title":"Detection of subclinical ultrasound enthesopathy and nail disease in patients at risk of psoriatic arthritis","volume":"84","author":"Acquitter","year":"2017","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib64","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10067-016-3319-5","article-title":"Psoriatic nail involvement and its relationship with distal interphalangeal joint disease","volume":"35","author":"Lai","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib65","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/1744666X.2017.1262765","article-title":"State of the art of ultrasound in the assessment of psoriasis and psoriatic arthritis","volume":"13","author":"Gutierrez","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib66","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ad.2015.02.005","article-title":"Nail psoriasis as a predictor of the development of psoriatic arthritis","volume":"106","author":"Raposo","year":"2015","journal-title":"Acta Dermosifiliogr"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib67","first-page":"1302","article-title":"Measuring dactylitis in clinical trials: which is the best instrument to use?","volume":"34","author":"Healy","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib68","first-page":"1745","article-title":"Development of an assessment tool for dactylitis in patients with psoriatic arthritis","volume":"32","author":"Helliwell","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib69","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12016-012-8304-4","article-title":"Imaging in psoriatic arthritis","volume":"44","author":"Anandarajah","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib70","doi-asserted-by":"crossref","first-page":"390726","DOI":"10.1155\/2011\/390726","article-title":"Usefulness of ultrasound imaging in detecting psoriatic arthritis of fingers and toes in patients with psoriasis","volume":"2011","author":"De Simone","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib71","doi-asserted-by":"crossref","first-page":"e0171704","DOI":"10.1371\/journal.pone.0171704","article-title":"The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity\u2014a systematic review","volume":"12","author":"Olchowy","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib72","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/ard.2007.076091","article-title":"The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis","volume":"67","author":"Anandarajah","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib73","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/ard.2008.100149","article-title":"Effect of adalimumab on joint disease: features of patients with psoriatic arthritis detected by magnetic resonance imaging","volume":"69","author":"Anandarajah","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib74","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/ard.2006.063818","article-title":"Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis","volume":"66","author":"Marzo-Ortega","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib75","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/1346-8138.13014","article-title":"Adalimumab markedly improves enthesitis in patients with psoriatic arthritis: evaluation with a magnetic resonance imaging scoring system","volume":"42","author":"Yanaba","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3899\/jrheum.150347","article-title":"Evaluation of magnetic resonance imaging responsiveness in active psoriatic arthritis at multiple timepoints during the first 12 weeks of antitumor necrosis factor therapy","volume":"43","author":"Feletar","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib77","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3899\/jrheum.090352","article-title":"The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA Hands","volume":"36","author":"Ostergaard","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib78","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.3899\/jrheum.141010","article-title":"Validation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) for the hand and foot in a randomized placebo-controlled trial","volume":"42","author":"Glinatsi","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib79","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.3899\/jrheum.110420","article-title":"The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) is reliable and sensitive to change: results from an OMERACT workshop","volume":"38","author":"B\u00f8yesen","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib80","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/art.20967","article-title":"Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)","volume":"52","author":"Antoni","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib81","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/ard.2004.032268","article-title":"Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial","volume":"64","author":"Antoni","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib82","doi-asserted-by":"crossref","first-page":"c147","DOI":"10.1136\/bmj.c147","article-title":"Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial","volume":"340","author":"Sterry","year":"2010","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib83","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1002\/art.21306","article-title":"Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial","volume":"52","author":"Mease","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib84","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3899\/jrheum.100069","article-title":"Responses to adalimumab in patients with active psoriatic arthritis who have not adequately responded to prior therapy: effectiveness and safety results from an open-label study","volume":"37","author":"Gladman","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib85","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/ard.2009.111856","article-title":"Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions","volume":"69","author":"Van den Bosch","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib86","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2013-203696","article-title":"Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)","volume":"73","author":"Mease","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib87","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/art.24403","article-title":"Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study","volume":"60","author":"Kavanaugh","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib88","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(13)60594-2","article-title":"Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial","volume":"382","author":"McInnes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib89","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2013-204655","volume":"73","author":"Ritchlin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib90","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(09)60140-9","article-title":"Ustekinumab, a human interleukin 12\/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial","volume":"373","author":"Gottlieb","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib91","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(15)61134-5","article-title":"Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"McInnes","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib92","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa1412679","article-title":"Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis","volume":"373","author":"Mease","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","volume":"76","author":"Mease","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib94","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/S0140-6736(17)31429-0","article-title":"Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial","volume":"389","author":"Nash","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib95","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1315231","article-title":"Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis","volume":"370","author":"Mease","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib96","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/art.39700","article-title":"The efficacy and safety of clazakizumab, an anti-interleukin-6 monoclonal antibody, in a phase IIb study of adults with active psoriatic arthritis","volume":"68","author":"Mease","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib97","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/annrheumdis-2016-210724","article-title":"Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis","volume":"76","author":"Mease","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"suppl 10","key":"10.1016\/j.semarthrit.2018.02.002_bib98","article-title":"Efficacy and safety of tofacitinib, an oral janus kinase inhibitor, or adalimumab in patients with active psoriatic arthritis and an inadequate response to conventional synthetic DMARDs: a randomized, placebo-controlled, phase 3trial [abstract]","volume":"68","author":"Mease","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"suppl 10","key":"10.1016\/j.semarthrit.2018.02.002_bib99","volume":"28","author":"Gladman","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib100","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/annrheumdis-2013-205056","article-title":"Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor","volume":"73","author":"Kavanaugh","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib101","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.3899\/jrheum.151376","article-title":"A phase III, randomized, controlled trial of apremilast in patients with poriatic athritis: results of the PALACE 2 trial","volume":"43","author":"Cutolo","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib102","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/annrheumdis-2015-207963","article-title":"Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)","volume":"75","author":"Edwards","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib103","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/art.1780391210","article-title":"Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study","volume":"39","author":"Clegg","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib104","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/art.11201","article-title":"Efficacy of infliximab in resistant psoriatic arthritis","volume":"49","author":"Salvarani","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijmyco.2015.05.006","article-title":"Osteoarticular tuberculosis dactylitis: four cases","volume":"4","author":"Sbai","year":"2015","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.semarthrit.2018.02.002_bib106","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11926-011-0184-8","article-title":"Review of the use of ultrasound for the diagnosis and monitoring of enthesitis in psoriatic arthritis","volume":"13","author":"Kaeley","year":"2011","journal-title":"Curr Rheumatol Rep"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017217306261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017217306261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,5]],"date-time":"2018-11-05T19:34:16Z","timestamp":1541446456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017217306261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0049017217306261"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2018.02.002","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dactylitis: A hallmark of psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2018.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}